James R. Taylor - Publications, H-index & Citations

James R. Taylor

University of Florida

54H指数

323论文数

1.2W被引数

收录论文 15

发表时间

The UK doesn't have a sick note culture, but it does have a broken benefits

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2024-05-10

OAAI

Taylor, James

Use of Dulaglutide, Semaglutide, and Tirzepatide in Diabetes and Weight Management 杜拉鲁肽、Semaglutide和Tirzepatide在糖尿病和体重管理中的应用

CLINICAL THERAPEUTICS

IF3.6

2024-03-01

PREAI

Powell, Jason; Taylor, James

Oral Semaglutide: The First-available Noninjectable Glucagon-like Peptide 1 Receptor Agonist 口服Semaglutide: 首个不可注射的胰高血糖素样肽1受体激动剂

CLINICAL THERAPEUTICS

IF3.6

2020-10-01

PREAI

Powell, Jason; Piszczatoski, Chris; Taylor, James R.

Microfluidic Manufacture of RNA-Lipid Nanoparticles Leads to Highly Efficient Delivery of Potent Nucleic Acid Therapeutics for Controlling Gene Expression

MOLECULAR THERAPY

IF12

2016-05-01

OAAI

Tharmarajah, Grace; Ouellet, Eric; Seira, Oscar; Liu, Jie; Thomas, Anitha; Leaver, Timothy; Wild, Andre; Li, Yuping; Wang, Yu Tian; Tetzlaff, Wolfram; Hansen, Carl; Cullis, Pieter; Taylor, James R.; Ramsay, Euan

Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin

CARDIOVASCULAR THERAPEUTICS

IF3.4

2015-05-12

OAAI

Carris, Nicholas W.; Spinelli, Alisa; Pierini, Danielle; Taylor, James R.; Anderson, Katherine Vogel; Sando, Karen; Powell, Jason; Rosenberg, Eric I.; Zumberg, Marc S.; Smith, Steven M.; Gums, John G.; Dietrich, Eric

Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists

CLINICAL THERAPEUTICS

IF3.6

2015-03-01

PREAI

Lindamood, Christopher A.; Taylor, James R.

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations

DRUGS

IF14.4

2014-11-21

PREAI

Carris, Nicholas W.; Taylor, James R.; Gums, John G.